Six drug companies including Mylan NV and Teva Pharmaceuticals have lost a bid to dismiss lawsuits accusing them of engaging in a scheme to fix prices for the generic blood pressure medication propranolol.
US District Judge Jed Rakoff in Manhattan on Thursday largely denied the drug companies’ motions to dismiss the proposed class actions, tossing only certain state-law claims brought by direct purchasers of propranolol.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
